02-2008-0812Administrative - FormalClosedFY 2008· Region 02
EPA v. West-Ward Pharmaceutical Corp.
Source Agrees
Case summary
Self-disclosure under the Audit Policy. The facility failed to file a TRI Form R report for lithium carbonate for 2004. The facility came into compliance on September 19 2006.
Defendants (1)
- West-Ward Pharmaceutical Corp.Named in settlement
Facilities (1)
WEST-WARD PHARMACEUTICAL CORP
465 INDUSTRIAL WAY W, EATONTOWN, NJ, 07724
Registry ID: 110001543580
Statutes cited
- EPCRA 313 — Toxic Chemical Release Reporting (TRI)
Enforcement conclusions (1)
West-Ward Pharmaceutical Corp.entered 2009-04-17
Primary law: EPCRA
Timeline (3 milestones)
- 2009-04-17Enforcement Action Closed
- 2009-04-17Final Order Issued
- 2009-04-21Enforcement Action Data Entered
Case metadata
- EPA activity ID
- 1400041099
- Case number
- 02-2008-0812
- Lead agency
- EPA
- Branch
- WTS
- EPA region
- 02
- Voluntary self-disclosure
- Yes
- Primary statute
- Toxic Chemical Release Reporting (TRI)
Sourced verbatim from EPA ECHO Enforcement Case Report for case 02-2008-0812 . Bulk data: ICIS-FEC download summary.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.